Approval of the patient care line with rare diseases, Brazil’s Portaria 199 and its National Policy. What does that mean? What changes?
The concept of rare disease (RD), according to the World Health Organization (WHO), is a disease that affects up to 65 people in every 100 thousand individuals, that means 1.3 for each 2 thousand people. In Brazil, it is estimated that 13 million people have rare diseases (RDs), most of them reachin...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2017 |
| País: | Brasil |
| Institución: | Universidade Federal do Ceará (UFC) |
| Repositorio: | Revista de Medicina da UFC |
| Idioma: | portugués |
| OAI Identifier: | oai:periodicos.ufc:article/20090 |
| Acceso en línea: | https://periodicos.ufc.br/revistademedicinadaufc/article/view/20090 |
| Access Level: | acceso abierto |
| Palabra clave: | Rare diseases |
| Sumario: | The concept of rare disease (RD), according to the World Health Organization (WHO), is a disease that affects up to 65 people in every 100 thousand individuals, that means 1.3 for each 2 thousand people. In Brazil, it is estimated that 13 million people have rare diseases (RDs), most of them reaching children, more than half of whom are diagnosed late. RDs are usually chronic, progressive, debilitating, unhealing, with decreasing loss of autonomy by the patient, who faces along with his family prejudices and lack of hope in healing and in therapies. |
|---|